# Definitive Hypofractionated Intensity-modulated Radiation Theraphy With Concurrent Chemotherapy in Cervical Cancer

> **NCT07439497** · PHASE2 · RECRUITING · sponsor: **Samsung Medical Center** · enrollment: 34 (estimated)

## Conditions studied

- Cervical Cancer

## Interventions

- **RADIATION:** Definitive hypofractionated intensity-modulated radiation theraphy
- **DRUG:** concurrent chemotherapy

## Key facts

- **NCT ID:** NCT07439497
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-09
- **Primary completion:** 2026-05-30
- **Final completion:** 2028-05-30
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07439497

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07439497, "Definitive Hypofractionated Intensity-modulated Radiation Theraphy With Concurrent Chemotherapy in Cervical Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07439497. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*